Alejandro Cencerrado Treviño

Alejandro Cencerrado Treviño

Auto-generated profile, based on publicly available information

Alejandro Cencerrado Treviño

Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Maria Jose De Jesus ValleMaria Jose De Jesus Valle
Maria Jose De Jesus Valle
ACAránzazu Zarzuelo Castañeda
Aránzazu Zarzuelo Castañeda
CMCristina Maderuelo
Cristina Maderuelo
ATAlejandro Cencerrado Treviño
Alejandro Cencerrado Treviño
JLJorge Loureiro
Jorge Loureiro
Amparo Sánchez NavarroAmparo Sánchez Navarro
Amparo Sánchez Navarro
A pharmaceutical vehicle based on lyophilized liposomes is proposed for the buccal administration of drugs aimed at systemic delivery through the sublingual mucosa. Liposomes made of egg phosphatidylcholine and cholesterol (7/3 molar ratio) were prepared and lyophilized in the presence of different additive mixtures with mucoadhesive and taste-masking properties. Palatability was assayed on healthy volunteers. The lyophilization cycle was optimized, and the lyophilized product was compressed to obtain round and capsule-shaped tables that were evaluated in healthy volunteers. Tablets were also assayed regarding weight and thickness uniformities, swelling index and liposome release. The results proved that lyophilized liposomes in unidirectional round tablets have palatability, small size, comfortability and buccal retention adequate for sublingual administration. In contact with water fluids, the tablets swelled, and rehydrated liposomes were released at a slower rate than permeation efficiency determined using a biomimetic membrane. Permeability efficiency values of 0.72 ± 0.34 µg/cm2/min and 4.18 ± 0.95 µg/cm2/min were obtained for the liposomes with and without additives, respectively. Altogether, the results point to the vehicle proposed as a liposomal formulation suitable for systemic drug delivery through the sublingual mucosa.